Jilin Aodong Pharmaceutical Group Co Ltd (000623) — Cash Flow Reinvestment Rate
Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥25.80 Million (capex CN¥25.80 Million ) from operating cash flow of CN¥112.12 Million. See Jilin Aodong Pharmaceutical Group Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Jilin Aodong Pharmaceutical Group Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see Jilin Aodong Pharmaceutical Group Co Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Jilin Aodong Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Jilin Aodong Pharmaceutical Group Co Ltd. See Jilin Aodong Pharmaceutical Group Co Ltd (000623) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.17x | CN¥862.15 Million | CN¥272.26 Million | CN¥128.45 Million | ▼ -80.8% |
| 2024 | 16.48x | CN¥980.49 Million | CN¥59.48 Million | CN¥273.98 Million | ▼ -5.2% |
| 2023 | 17.38x | CN¥1.18 Billion | CN¥68.06 Million | CN¥419.52 Million | ▲ +432.8% |
| 2022 | 3.26x | CN¥1.38 Billion | CN¥423.86 Million | CN¥270.97 Million | ▼ -24.0% |
| 2021 | 4.29x | CN¥1.39 Billion | CN¥324.85 Million | CN¥313.30 Million | ▲ +417.1% |
| 2020 | 0.83x | CN¥323.95 Million | CN¥390.41 Million | CN¥227.38 Million | ▼ -4.3% |
| 2019 | 0.87x | CN¥328.96 Million | CN¥379.46 Million | CN¥222.40 Million | ▼ -87.2% |
| 2018 | 6.76x | CN¥2.35 Billion | CN¥347.64 Million | CN¥245.30 Million | ▲ +217.9% |
| 2017 | 2.13x | CN¥545.48 Million | CN¥256.49 Million | CN¥83.93 Million | ▼ -3.8% |
| 2016 | 2.21x | CN¥738.12 Million | CN¥333.81 Million | CN¥158.03 Million | ▼ -40.3% |
| 2015 | 3.70x | CN¥1.44 Billion | CN¥388.03 Million | CN¥334.11 Million | ▲ +166.0% |
| 2014 | 1.39x | CN¥402.01 Million | CN¥288.83 Million | CN¥402.01 Million | ▼ -9.4% |
| 2013 | 1.54x | CN¥309.01 Million | CN¥201.22 Million | CN¥309.01 Million | ▲ +28.0% |
| 2012 | 1.20x | CN¥326.80 Million | CN¥272.40 Million | CN¥326.80 Million | ▼ -71.6% |
| 2011 | 4.23x | CN¥457.72 Million | CN¥108.30 Million | CN¥457.72 Million | ▲ +384.4% |
| 2010 | 0.87x | CN¥152.00 Million | CN¥174.22 Million | CN¥152.00 Million | ▲ +409.0% |
| 2009 | 0.17x | CN¥36.51 Million | CN¥213.03 Million | CN¥36.51 Million | ▲ +27.8% |
| 2008 | 0.13x | CN¥31.52 Million | CN¥235.03 Million | CN¥31.52 Million | ▲ +31.5% |
| 2007 | 0.10x | CN¥39.24 Million | CN¥384.69 Million | CN¥39.24 Million | ▼ -66.3% |
| 2006 | 0.30x | CN¥56.87 Million | CN¥187.99 Million | CN¥56.87 Million | ▼ -26.0% |
| 2005 | 0.41x | CN¥55.68 Million | CN¥136.26 Million | CN¥55.68 Million | ▲ +93.4% |
| 2004 | 0.21x | CN¥46.19 Million | CN¥218.53 Million | CN¥46.19 Million | ▼ -66.0% |
| 2003 | 0.62x | CN¥91.89 Million | CN¥147.65 Million | CN¥91.89 Million | ▼ -58.4% |
| 2001 | 1.49x | CN¥207.37 Million | CN¥138.76 Million | CN¥207.37 Million | ▼ -29.8% |
| 2000 | 2.13x | CN¥163.90 Million | CN¥77.04 Million | CN¥163.90 Million | ▲ +232.4% |
| 1999 | 0.64x | CN¥70.52 Million | CN¥110.18 Million | CN¥70.52 Million | — |